- AU$130.19bn
- AU$150.55bn
- $13.31bn
- 77
- 16
- 60
- 52
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,539 | 9,151 | 10,310 | 10,562 | 13,310 |
Cost of Revenue | |||||
Gross Profit | 4,777 | 5,226 | 5,843 | 5,732 | 6,844 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6,035 | 6,434 | 7,180 | 7,635 | 10,241 |
Operating Profit | 2,504 | 2,717 | 3,130 | 2,927 | 3,069 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,341 | 2,573 | 2,963 | 2,780 | 2,663 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,919 | 2,103 | 2,375 | 2,255 | 2,244 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,919 | 2,103 | 2,375 | 2,255 | 2,194 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1,919 | 2,103 | 2,375 | 2,255 | 2,194 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.57 | 4.95 | 5.37 | 5.03 | 4.85 |
Dividends per Share |